Neonatal screening for cystic fibrosis does not affect time to first infection with Pseudomonas aeruginosa

Pediatrics

Volumn 118, Issue 3, 2006, Pages 888-895

  Baussano, Iacopo ^a,b   Tardivo, Irene ^b   Bellezza Fontana, Rossana ^b   Forneris, Maria Pia ^b   Lezo, Antonella ^b   Anfossi, Luciano ^b   Castello, Mario ^b   Aleksandar, Veljkovic ^b   Bignamini, Elisabetta ^b  

^a UNIVERSITY OF TURIN   (Italy)

^b ASO OIRM Sant'Anna   (Italy)

Author keywords

Cystic fibrosis; Infection; Screening

Indexed keywords

PANCREAS ENZYME;

ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; FEMALE; GRAM NEGATIVE INFECTION; HAZARD RATIO; HUMAN; MAJOR CLINICAL STUDY; MALE; MECONIUM ILEUS; NEWBORN; NEWBORN SCREENING; PANCREAS FUNCTION; PANCREAS INSUFFICIENCY; PEDIATRIC HOSPITAL; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SURVIVAL; CASE CONTROL STUDY; CHILD; COHORT ANALYSIS; INFANT; PRESCHOOL CHILD; RISK FACTOR; TIME; UTILIZATION REVIEW;

CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; CYSTIC FIBROSIS; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; NEONATAL SCREENING; PSEUDOMONAS INFECTIONS; RISK FACTORS; TIME FACTORS;

EID: 33749078004     PISSN: 00314005     EISSN: 02105721     Source Type: Journal    
DOI: 10.1542/peds.2004-2599     Document Type: Article

References (33)

1. Wildhagen MF, Kate LP, Habbema JD. Screening for cystic fibrosis and its evaluation. Br Med Bull. 1998;54:857-875
2. Wald NJ, Morris JK. Neonatal screening for cystic fibrosis. BMJ. 1998;316:404-405
3. Dankert-Roelse JE, Meerman GJ. Screening for cystic fibrosis: time to change our position? N Engl J Med. 1997;337:997-999
4. American Society of Human Genetics, Ad Hoc Committee on Cystic Fibrosis Carrier Screening. Statement of the American Society of Human Genetics on cystic fibrosis carrier screening. Am J Hum Genet. 1992;51:1443-1444
5. Centers for Disease Control and Prevention. Newborn screening for cystic fibrosis: a paradigm for public health genetics policy development - proceedings of a 1997 workshop. MMWR Recomm Rep. 1997;46(RR-16):1-24
6. Farrell PM. Cystic fibrosis newborn screening: shifting the key question from "should we screen?" to "how should we screen?" Pediatrics. 2004;113:1811-1812
7. Grosse SD, Boyle CA, Botkin JR, et al. Newborn screening for cystic fibrosis: evaluation of benefits and risks and recommendations for state newborn screening programs. MMWR Recomm Rep. 2004;53(RR-13):1-36
8. Dankert-Roelse JE, Merelle ME. Review of outcomes of neonatal screening for cystic fibrosis versus non-screening in Europe. J Pediatr. 2005;147:S15-S20
9. Farrell PM, Lai HJ, Li Z, et al. Evidence on improved outcomes with early diagnosis of cystic fibrosis through neonatal screening: enough is enough! J Pediatr. 2005;147:S30-S36
10. Rosenfeld M. Overview of published evidence on outcomes with early diagnosis from large US observational studies. J Pediatr. 2005;147:S11-S14
11. Koscik RL, Douglas JA, Zaremba K, et al. Quality of life of children with cystic fibrosis. J Pediatr. 2005;147:S64-S68
12. Vonberg RP, Gastmeier P. Isolation of infectious cystic fibrosis patients: results of a systematic review. Infect Control Hosp Epidemiol. 2005;26:401-409
13. Kosorok MR, Zeng L, West SE, et al. Acceleration of lung disease in children with cystic fibrosis after Pseudomonas aeruginosa acquisition. Pediatr Pulmonol. 2001;32:277-287
14. Frederiksen B, Koch C, Hoiby N. Antibiotic treatment of initial colonization with Pseudomonas aeruginosa postpones chronic infection and prevents deterioration of pulmonary function in cystic fibrosis. Pediatr Pulmonol. 1997;23:330-335
15. Emerson J, Rosenfeld M, McNamara S, Ramsey B, Gibson RL. Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis. Pediatr Pulmonol. 2002;34:91-100
16. Merelle ME, Nagelkerke AF, Lees CM, Dezateux C. Newborn screening for cystic fibrosis. Cochrane Database Syst Rev. 2001;(3):CD001402
17. Kosorok MR, Jalaluddin M, Farrell PM, et al. Comprehensive analysis of risk factors for acquisition of Pseudomonas aeruginosa in young children with cystic fibrosis. Pediatr Pulmonol. 1998;26:81-88
18. Sims EJ, McCormick J, Mehta G, Mehta A. Neonatal screening for cystic fibrosis is beneficial even in the context of modern treatment. J Pediatr. 2005;147:S42-S46
19. Bossi A, Battistini F, Braggion C, et al. Italian Cystic Fibrosis Registry: 10 years of activity [in Italian]. Epidemiol Prev. 1999;23:5-16
20. Padoan R, Pardo F, Giglio L, Bossi A. Regional differences in the incidence of cystic fibrosis in Italy. Ital J Pediatr. 2001;27:876-886
21. Deliberazione della Giunta Regionale, No. 36-9747. Bollettino Ufficiale Torino, Italy, June 26, 2003
22. Decreto Del Presidente Del Consiglio Dei Ministri. Population of the Italian republic according to the national census, 21st October 2001 [in Italian]. Gazzetta Ufficiale Serie Generale 2003; No. 81
23. Tomaiuolo R, Spina M, Castaldo G. Molecular diagnosis of cystic fibrosis: comparison of four analytical procedures. Clin Chem Lab Med. 2003;41:26-32
24. Bull K, Spiegelhalter DJ. Survival analysis in observational studies. Stat Med. 1997;16:1041-1074
25. Maselli JH, Sontag MK, Norris JM, MacKenzie T, Wagener JS, Accurso FJ. Risk factors for initial acquisition of Pseudomonas aeruginosa in children with cystic fibrosis identified by newborn screening. Pediatr Pulmonol. 2003;35:257-262
26. Boyton RJ, Openshaw PJ. Pulmonary defences to acute respiratory infection. Br Med Bull. 2002;61:1-12
27. American Academy of Pediatrics. NBS Task Force. Newborn screening: a blueprint for the future executive summary: newborn screening task force report. Pediatrics. 2000;106:386-388
28. Farrell PM, Shen G, Splaingard M, et al. Acquisition of Pseudomonas aeruginosa in children with cystic fibrosis. Pediatrics. 1997;100(2). Available at: www.pediatrics.org/cgi/content/full/100/2/e2
29. Wang SS, FitzSimmons SC, O'Leary LA, Rock MJ, Gwinn ML, Khoury MJ. Early diagnosis of cystic fibrosis in the newborn period and risk of Pseudomonas aeruginosa acquisition in the first 10 years of life: a registry-based longitudinal study. Pediatrics. 2001;107:274-279
30. Egger M, George DS, O'Rourke K. Rationale, potentials, and promise of systematic reviews. In: Egger M, George DS, O'Rourke K, eds. Systematic Reviews in Health Care. London, United Kingdom: BMJ Publishing Group; 2001:3-19
31. Johansen HK, Nir M, Hoiby N, Koch C, Schwartz M. Severity of cystic fibrosis in patients homozygous and heterozygous for delta F508 mutation. Lancet. 1991;337:631-634
32. Mohon RT, Wagener JS, Abman SH, Seltzer WK, Accurso FJ. Relationship of genotype to early pulmonary function in infants with cystic fibrosis identified through neonatal screening. J Pediatr. 1993;122:550-555
33. Demko CA, Byard PJ, Davis PB. Gender differences in cystic fibrosis: Pseudomonas aeruginosa infection. J Clin Epidemiol. 1995;48:1041-1049